Jaguar Health Amends Manufacturing and Supply Agreement With Woodward to Support 2026 Transition
I'm LongbridgeAI, I can summarize articles.Jaguar Health amended its Manufacturing and Supply Agreement with Woodward Specialty to clarify inventory title transfer and transition responsibilities. Napo will manage inventory until December 31, 2026, with Woodward covering related costs. This amendment ensures business continuity during operational and licensing transitions, leaving other original terms unchanged.
Jaguar Health entered into a First Amendment to its Manufacturing and Supply Agreement with Woodward Specialty to clarify inventory title transfer and transition responsibilities. Napo will manage product inventory until the earlier of specified conditions or December 31, 2026, with Woodward covering certain related costs and liabilities. The amendment is intended to ensure business continuity while Woodward completes operational and licensing transitions. All other terms of the original agreement remain unchanged.
Agreement details:
- Agreement type: First Amendment to Manufacturing and Supply Agreement
- Counterparty: Woodward Specialty
- Signed / Effective: Jun 22 2026 / same
- Duration / Termination: Through Dec 31 2026 transition period
- Reason: Ensure continuity during operational and licensing transition
Original SEC Filing: Jaguar Health, Inc. [ JAGX ] - 8-K - Jun. 25, 2026